Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Location: United States, Washington, Seattle
Employees: 201-500
Founded date: 1994
Investors 4
| Date | Name | Website |
| - | Puget Soun... | pugetsound... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | CRG | crglp.com |
| - | SpringRock... | springrock... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 03.12.2021 | OMEROS ANNOUNCES AGREEMENT TO SELL OMIDRIA FRANCHISE TO RAYN... | SEATTLE - Omeros Corporation (Nasdaq: OMER) announced that it has entered into a definitive agreemen... | marketscre... |
| 02.12.2021 | Omeros : Announces Agreement to Sell OMIDRIA® Franchise to R... | Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in ... | marketscre... |
| 02.12.2021 | Omeros Announces Agreement to Sell OMIDRIA® Franchise to Ray... | Omeros Corporation (Nasdaq: OMER) today announced that it has entered into a definitive agreement fo... | marketscre... |
| 31.10.2014 | Tetra Discovery Lands Funding, Plans Alzheimer’s Drug Trial ... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Grand Rapids, MI-based biotech sta... | xconomy.co... |
| 06.10.2008 | ChemoCentryx raises $50M, eyes bleak IPO landscape for biote... | ChemoCentryx Inc., a biotech company that develops drugs to treat immune system ailments, got a $50 ... | venturebea... |